We are live on ! Find out more

786 hedge funds and large institutions have $17B invested in Labcorp in 2018 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 280 increasing their positions, 301 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

143% more call options, than puts

Call options by funds: $64.5M | Put options by funds: $26.6M

36% more funds holding in top 10

Funds holding in top 10: 1419 (+5)

11% more capital invested

Capital invested by funds: $15.4B → $17B (+$1.63B)

2% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 61

1% less funds holding

Funds holding: 792786 (-6)

0.81% less ownership

Funds ownership: 108.83%108.02% (-0.81%)

7% less repeat investments, than reductions

Existing positions increased: 280 | Existing positions reduced: 301

Holders
786
Holders Change
-6
Holders Change %
-0.76%
% of All Funds
17.92%
Holding in Top 10
19
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+35.71%
% of All Funds
0.43%
New
62
Increased
280
Reduced
301
Closed
61
Calls
$64.5M
Puts
$26.6M
Net Calls
+$38M
Net Calls Change
+$38.6M

LH Hedge Fund Activity: Q2 2018 in Review

786 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q2 2018, worth a combined $17B — up 11% from $15.4B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new LH positions and 61 closed out — a net gain of 1 holder — while 280 added to existing stakes and 301 trimmed.

The largest buyer was Amundi Asset Management US, adding an estimated $228M. The largest seller was Glenview Capital Management, cutting an estimated $237M.

  • 786 institutional investors held Labcorp (LH) as of Q2 2018, down from 792 in Q1 2018.
  • Funds reported $17B of Labcorp stock for Q2 2018, up 11% quarter-over-quarter.
  • 62 funds opened new Labcorp positions in Q2 2018 and 61 closed out, a net change of +1 holder.
  • The largest Labcorp buyer in Q2 2018 was Amundi Asset Management US, an estimated $228M added.
  • The largest Labcorp seller in Q2 2018 was Glenview Capital Management, an estimated $237M sold.

Based on aggregated 13F filings for Q2 2018.